These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36600157)

  • 1. ESG performance in the time of COVID-19 pandemic: cross-country evidence.
    Al Amosh H; Khatib SFA
    Environ Sci Pollut Res Int; 2023 Mar; 30(14):39978-39993. PubMed ID: 36600157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESG Performance and Stock Price Volatility in Public Health Crisis: Evidence from COVID-19 Pandemic.
    Zhou D; Zhou R
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding how ESG-focused airlines reduce the impact of the COVID-19 pandemic on stock returns.
    Chen CD; Su CJ; Chen MH
    J Air Transp Manag; 2022 Jul; 102():102229. PubMed ID: 35599747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental, social, and governance (ESG) model; impacts and sustainable investment - Global trends and Poland's perspective.
    Dmuchowski P; Dmuchowski W; Baczewska-DÄ…browska AH; Gworek B
    J Environ Manage; 2023 Mar; 329():117023. PubMed ID: 36571952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of ESG performance on the stock market during the COVID-19 Pandemic - Evidence from Japan.
    Liu L; Nemoto N; Lu C
    Econ Anal Policy; 2023 Jun; ():. PubMed ID: 38620119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does ESG performance affect stock returns? Empirical evidence from listed companies in China.
    Yin XN; Li JP; Su CW
    Heliyon; 2023 May; 9(5):e16320. PubMed ID: 37305472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ESG performance during times of financial crisis: Evidence from COVID-19 in China.
    Broadstock DC; Chan K; Cheng LTW; Wang X
    Financ Res Lett; 2021 Jan; 38():101716. PubMed ID: 32837385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ESG performance during times of COVID-19 pandemic.
    Gao M; Geng X
    Sci Rep; 2024 Jan; 14(1):2553. PubMed ID: 38297089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental, social, and governance (ESG) performance and financial outcomes: Analyzing the impact of ESG on financial performance.
    Chen S; Song Y; Gao P
    J Environ Manage; 2023 Nov; 345():118829. PubMed ID: 37688968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does sustainability activities performance matter during financial crises? Investigating the case of COVID-19.
    Yoo S; Keeley AR; Managi S
    Energy Policy; 2021 Aug; 155():112330. PubMed ID: 35722223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESG performance, investor attention, and company reputation: Threshold model analysis based on panel data from listed companies in China.
    Meng T; Dato Haji Yahya MH; Ashhari ZM; Yu D
    Heliyon; 2023 Oct; 9(10):e20974. PubMed ID: 37876450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritizing CSR components for value enhancement: Evidence from the financial industry in developed and emerging markets.
    Jitmaneeroj B
    Heliyon; 2023 May; 9(5):e16044. PubMed ID: 37215907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the fast track: the benefits of ESG performance on the commercial credit financing.
    Huang Y; Bai F; Shang M; Ahmad M
    Environ Sci Pollut Res Int; 2023 Jul; 30(35):83961-83974. PubMed ID: 37351751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ESG performance influence mechanism analysis-based on empirical analysis.
    Ma L; Yuan X; Lu J; Li Y; Gao W; Yan H; Zhang X
    PLoS One; 2024; 19(5):e0295548. PubMed ID: 38743654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do environmental, social, and governance scores improve green innovation? Empirical evidence from Chinese-listed companies.
    Zhang C; Chen D
    PLoS One; 2023; 18(5):e0279220. PubMed ID: 37228130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantity and quality: The impact of environmental, social, and governance (ESG) performance on corporate green innovation.
    Zhang H; Lai J; Jie S
    J Environ Manage; 2024 Mar; 354():120272. PubMed ID: 38394870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESG practices mitigating geopolitical risks: Implications for sustainable environmental management.
    Alnafrah I
    J Environ Manage; 2024 May; 358():120923. PubMed ID: 38652985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the nexus between environmental, social, and governance (ESG) and financial performance: evidence from Chinese-listed companies.
    Zhou R; Hou J; Ding F
    Environ Sci Pollut Res Int; 2023 Jun; 30(29):73231-73253. PubMed ID: 37184789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing asymmetric price efficiency in regional ESG markets before and during COVID-19.
    Naeem MA; Yousaf I; Karim S; Tiwari AK; Farid S
    Econ Model; 2023 Jan; 118():106095. PubMed ID: 36341042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the performance of responsible companies in G20 during the COVID-19 outbreak.
    El Khoury R; Nasrallah N; Harb E; Hussainey K
    J Clean Prod; 2022 Jun; 354():131693. PubMed ID: 35440858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.